ReproCELL Incorporated (4978) Other
Market cap
¥16.2B
P/E ratio
-28.2x
Reprocell develops iPS cell technology for research and medical applications, providing lab products and services to pharmaceutical companies while advancing regenerative medicine treatments.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Return on Assets | - | - | - | - | -16.6 | -4.6 | -21 | -2.4 | -5 | -2.4 | -3.1 | -3.2 | -0.4 | 1.4 |
| Return on equity (%) | - | - | - | |||||||||||
| Employees | 12 | 10 | 14 | 50 | 73 | 60 | 63 | 111 | 113 | 106 | 98 | 92 | 96 | 99 |